POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes

COPD is a complex and heterogeneous disease characterized by chronic airway inflammation.1 The latter may alter airway antimicrobial defense systems and therefore favor the colonization of the bronchial mucosa by potentially pathogenic microorganisms (PPM).2 The most frequent PPMs that are capable of provoking clinical symptoms or that have impact in the COPD prognosis are listed here: Haemophilus influenza and parainfluenza, Streptococcus pneumoniae, Moraxella Catarrhalis, Pseudomonas aeruginosa, Staphylococcus aureus and some enterobacteriaceae. These PPMs, and more importantly, the presence of chronic bronchial infection (CBI), which is defined as the repeated isolation of PPMs from the airway overtime, could be a potential mechanism of disease progression and poor health outcomes in patients with COPD.3
Puedes leer el artículo completo aquí: https://journal.chestnet.org/article/S0012-3692(22)01251-X/fulltext
Noticias relacionadas
COPD multimorbidity management: A person-centred clinical approach to the multimorbid patient with COPD
Expert consensus on patient-centred strategies to manage multimorbidity in COPD, aiming to improve outcomes and reduce disease burden.
Chronic Airways Assessment Test (CAAT)
The CAAT is a standardized 8-item questionnaire to assess health status in people with asthma, COPD, and other airway diseases. Now validated beyond COPD.
Reply: Spirometry remains the GOLD standard test for COPD diagnosis
Commentary in the European Respiratory Journal (June 2025) reaffirming spirometry as the essential diagnostic tool for COPD.
Más artículos
COPD
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en Canva Pro el 18 de mayo de 2023.